[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Caredx Inc (CDNA)

Caredx Inc (CDNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,436,154
  • Shares Outstanding, K 51,734
  • Annual Sales, $ 379,810 K
  • Annual Income, $ -21,350 K
  • EBIT $ 108 M
  • EBITDA $ 130 M
  • 60-Month Beta 2.39
  • Price/Sales 6.52
  • Price/Cash Flow 7,346.39
  • Price/Book 5.82

Options Overview Details

View History
  • Implied Volatility 51.79% (+6.89%)
  • Historical Volatility 104.51%
  • IV Percentile 2%
  • IV Rank 5.84%
  • IV High 224.22% on 03/10/26
  • IV Low 41.09% on 05/14/26
  • Expected Move (DTE 16) 2.47 (5.32%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 66
  • Volume Avg (30-Day) 526
  • Put/Call OI Ratio 4.52
  • Today's Open Interest 9,895
  • Open Int (30-Day) 4,248
  • Expected Range 43.90 to 48.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.01
  • Number of Estimates 1
  • High Estimate $0.01
  • Low Estimate $0.01
  • Prior Year $0.03
  • Growth Rate Est. (year over year) -66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.32 +70.52%
on 07/08/26
49.76 -6.38%
on 08/03/26
+17.39 (+59.59%)
since 07/02/26
3-Month
19.61 +137.50%
on 05/18/26
49.76 -6.38%
on 08/03/26
+25.88 (+125.05%)
since 05/05/26
52-Week
11.26 +313.74%
on 08/07/25
49.76 -6.38%
on 08/03/26
+33.74 (+262.53%)
since 08/05/25

Most Recent Stories

More News
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced that, on July 30, 2026, CareDx granted to James McNally,...

CDNA : 46.66 (-0.91%)
CareDx: Q2 Earnings Snapshot

CareDx: Q2 Earnings Snapshot

CDNA : 46.66 (-0.91%)
CareDx Announces Second Quarter 2026 Financial Results

Second Quarter Revenue Growth of 52% to $132 Million Raises 2026 Revenue Guidance to $490 Million to $500 Million and Raises 2026 AEBITDA Guidance to $66 Million to $78...

CDNA : 46.66 (-0.91%)
CareDx's First Report Under Final Medicare Rules Will Reveal How Test Limits Actually Work

Barchart Research What to Expect from CDNA Earnings CDNA Generated July 29, 2026 Current Price $35.41 EPS Estimate $$0.06 Consensus Rating Moderate Buy Average Move 7.48% CareDx's First Report Under Final...

CDNA : 46.66 (-0.91%)
CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026

CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced it will report financial results for the second quarter...

CDNA : 46.66 (-0.91%)
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination

Coverage for Surveillance Testing Affirmed for Early Detection of Allograft Rejection in Kidney, Heart, and Lung

CDNA : 46.66 (-0.91%)
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology

NavDx ® is the only Medicare-covered MRD test for HPV-positive Head & Neck and Anal Cancers Expands CareDx’s estimated addressable market...

CDNA : 46.66 (-0.91%)
CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific

Sharpens focus on U.S. precision medicine Testing Services and Patient & Digital Solutions

CDNA : 46.66 (-0.91%)
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress

Growing body of evidence supports AlloSure ® as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomes Data across...

CDNA : 46.66 (-0.91%)
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology

AlloSure ® Kidney elevations are associated with increased risk of graft dysfunction and loss in kidney transplant recipients Data...

CDNA : 46.66 (-0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of...

See More

Key Turning Points

3rd Resistance Point 49.74
2nd Resistance Point 48.87
1st Resistance Point 47.98
Last Price 46.66
1st Support Level 46.22
2nd Support Level 45.35
3rd Support Level 44.46

See More

52-Week High 49.76
Last Price 46.66
Fibonacci 61.8% 35.05
Fibonacci 50% 30.51
Fibonacci 38.2% 25.97
52-Week Low 11.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.